|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01643 MODERN CHI MED
Nominal 
0.375 -0.030 (-7.407%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 214,068 | -37.784% | 344,075 | 399,656 | 360,695 | 308,692 |
| Cost of Sales | (158,871) | -33.776% | (239,900) | (228,870) | (202,267) | (171,831) |
| Gross Profit | 55,197 | -47.015% | 104,175 | 170,786 | 158,428 | 136,861 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | (14,367) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 14,819 | -78.305% | 68,306 | 124,324 | 114,222 | 90,478 | |
| Taxation | (5,149) | -73.610% | (19,511) | (36,495) | (32,446) | (26,901) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 9,670 | -80.182% | 48,795 | 87,829 | 81,776 | 63,577 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (765) | -15.094% | (901) | (661) | (347) | 111 |
| Depreciation & Amortisation | 9,274 | 44.006% | 6,440 | 5,691 | 2,723 | 1,835 |
| Directors' Emoluments | -- | -- | 1,637 | 1,666 | 1,952 | 1,174 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 1.610 | -80.197% | 8.130 | 14.640 | 13.770 | 14.130 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 1.361 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 9.881% | -- |
| Cash flow per share ($) | -- | -- | 0.014 | 0.210 | 0.097 | 0.095 |
| NBV per share ($) | 0.807 | -- | 0.788 | 0.705 | 0.562 | -- |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 9,670,000 |
| %Change | -80.182% |
| EPS / (LPS) | RMB 0.016 |
| NBV Per Share (¥) | RMB 0.807 |